Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare... see more

Bullboard (NDAQ:INM)

View:
Comment by MeanGreenon Sep 13, 2021 8:54am

RE:InMed To Acquire BayMedica In All-Stock Transaction Pegged A

Great to see this finally close. Hopefully a lot of other news and progress to follow. 
Post by AwareInvestoron Sep 13, 2021 8:49am

InMed To Acquire BayMedica In All-Stock Transaction Pegged A

InMed Pharmaceuticals is looking to acquire one of its competitors. The firm has entered into a definitive agreement to acquire BayMedica Inc, a specialty firm focused on manufacturing and ...more  
Post by Bullknit101on Sep 09, 2021 7:04pm

After Hours Rally

Decent volume this time: https://www.marketwatch.com/investing/stock/inm
Post by Bullknit101on Sep 09, 2021 2:49pm

Cannabis Pharma Report

https://prohibitionpartners.com/2021/09/09/the-pharmaceutical-cannabis-report-2nd-edition-key-insights/
Post by Bullknit101on Sep 08, 2021 12:26pm

Cannabinoids and Cancer Related Pain

https://www.benzinga.com/markets/cannabis/21/09/22850163/national-cancer-research-institute-endorses-study-on-cannabinoids-and-cancer-related-pain
Post by Bullknit101on Sep 07, 2021 10:59pm

Webcast Investor Conference

https://www.marketscreener.com/quote/stock/INMED-PHARMACEUTICALS-INC-18407562/news/InMed-Pharmaceuticals-to-Webcast-Live-at-VirtualInvestorConferences-com-September-8th-36367134/
Comment by Bullknit101on Sep 03, 2021 9:53am

RE:Wall Street Journal - Biosynthesis

Google Search on "Healing of Power Pot" and you may be able to read the full article without a subscription. It's just nice to see some visibly in the WSJ although they only mention ...more  
Post by Bullknit101on Sep 03, 2021 9:38am

Wall Street Journal - Biosynthesis

https://www.wsj.com/articles/cannabis-researchers-seek-to-unlock-the-healing-power-of-pot-11630674984
Post by Bullknit101on Sep 02, 2021 1:01am

Research for Medicines

https://www.marijuanamoment.net/dea-proposes-massive-increase-in-marijuana-and-psilocybin-production-for-research-to-develop-fda-approved-medicines/
Post by Bullknit101on Aug 31, 2021 11:18am

Minor Cannabinoids Study

https://www.naturalproductsinsider.com/herbs-botanicals/minor-cannabinoids-poised-spotlight
Post by Bullknit101on Aug 31, 2021 11:13am

Cardiol Thera

CRDL getting some attention recently: https://youtu.be/NItnK7ELGdU
Post by Bullknit101on Aug 31, 2021 8:24am

CBN

https://mjbizdaily.com/cannabinoid-cbn-might-be-surprise-hit-in-cannabis-industry/
Post by Bullknit101on Aug 25, 2021 10:13pm

ECS

https://www.health.harvard.edu/blog/the-endocannabinoid-system-essential-and-mysterious-202108112569
Post by Bullknit101on Aug 25, 2021 2:44pm

InMed Article

https://www.benzinga.com/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities